New Delhi: The mission of vaccine preparation is going on worldwide for the prevention of Coronavirus infection. But there is bad news in the meantime. The first vaccine being prepared for the prevention of the coronavirus has proved to be a failure in the trial. These vaccines have proved to be unsuccessful in winning the coronavirus during clinical trials. This has been revealed in the report released by the World Health Organization (WHO) with 'mistake'.
According to media reports, the Gilead company had prepared an antiviral vaccine for the prevention of coronavirus. But this vaccine has proved unsuccessful in clinical trials in China. According to the report Gilead's antiviral Remdesivir vaccine has proved to be unable to prevent coronavirus infection.
However, Gilead has reacted to this news saying that the report released by WHO is incomplete. The company claims that not many people were found in China for clinical trials. This is why the trial has not been completed yet.
Experts associated with the case say that most American and European companies have accelerated their trials. It is expected that the first vaccine will come in June or July. However, the launch of vaccines also depends on how quickly they meet safety standards.
Rajasthan Tourism App - Welcomes to the land of Sun, Sand and adventures